Antibodies: A Double Leg Takedown Against COVID-19

Mario U Mondelli^{1

2}

Affiliations

¹ Division of Clinical Immunology and Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Editorial

Mario U Mondelli. J Infect Dis. 2022.

. 2022 May 16;225(10):1685-1687.

doi: 10.1093/infdis/jiac061.

Mario U Mondelli^{1

2}

¹ Division of Clinical Immunology and Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

No abstract available

Comment on

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
Rieke GJ, van Bremen K, Bischoff J, ToVinh M, Monin MB, Schlabe S, Raabe J, Kaiser KM, Finnemann C, Odainic A, Kudaliyanage A, Latz E, Strassburg CP, Boesecke C, Schmidt SV, Krämer B, Rockstroh JK, Nattermann J. Rieke GJ, et al. J Infect Dis. 2022 May 16;225(10):1688-1693. doi: 10.1093/infdis/jiac060. J Infect Dis. 2022. PMID: 35323975 Free PMC article.

1. Center for Systems Science and Engineering, Johns Hopkins University. COVID- 2019 Dashboard. https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942.... Accessed 9 February 2022.
1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506. - PMC - PubMed
1. Goga A, Bekker L-G, Garrett N, et al. . Breakthrough Covid-19 infections during periods of circulating beta, delta and omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa. MedRxiv, doi: 10.1101/2021.12.21.21268171, 22. December 2021, preprint: not peer reviewed. - DOI
1. Deer RR, Rock MA, Vasilevsky N, et al. . Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine 2021; 74:103722. - PMC - PubMed
1. Diamond MS, Kanneganti T-D.. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol 2022; 23:165–76. - PMC - PubMed